Large-scale testing (Phase 3)Study completedNCT03986138What this trial is testingEfficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)Who this might be right forLesion in Body Region Guerbet 324
Large-scale testing (Phase 3)Study completedNCT07275723What this trial is testingA Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) LesionsWho this might be right forFor Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS) Shanghai Shengdi Pharmaceutical Co., Ltd 309
Early research (Phase 1)Study completedNCT01422135What this trial is testingPharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy FemalesWho this might be right forHealthy Agile Therapeutics 24
Large-scale testing (Phase 3)Study completedNCT06010173What this trial is testingEvaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and ChildrenWho this might be right forLesion in Body RegionCNS Lesion Guerbet 240